Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lipoprotein(a) in Youth and Prediction of Major Cardiovascular Outcomes in Adulthood
Olli T. Raitakari, Noora Kartiosuo, Katja Pahkala, et al.
Circulation (2022) Vol. 147, Iss. 1, pp. 23-31
Closed Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice
Marlys L. Koschinsky, Archna Bajaj, Michael B. Boffa, et al.
Journal of clinical lipidology (2024) Vol. 18, Iss. 3, pp. e308-e319
Closed Access | Times Cited: 74
Childhood Non-HDL Cholesterol and LDL Cholesterol and Adult Atherosclerotic Cardiovascular Events
Feitong Wu, Markus Juonala, David R. Jacobs, et al.
Circulation (2023) Vol. 149, Iss. 3, pp. 217-226
Closed Access | Times Cited: 24
Lipoprotein Apheresis: Current Recommendations for Treating Familial Hypercholesterolemia and Elevated Lipoprotein(a)
Maya Safarova, Patrick M. Moriarty
Current Atherosclerosis Reports (2023) Vol. 25, Iss. 7, pp. 391-404
Closed Access | Times Cited: 23
Subclinical atherosclerosis in young adults predicting cardiovascular disease: The Cardiovascular Risk in Young Finns Study
Olli T. Raitakari, Costan G. Magnussen, Markus Juonala, et al.
Atherosclerosis (2024), pp. 117515-117515
Open Access | Times Cited: 9
Prevention of cardiovascular disease in young adults: Focus on gender differences. A collaborative review from the EAS Young Fellows
Christina Antza, Antonio Gallo, Chrysoula Boutari, et al.
Atherosclerosis (2023) Vol. 384, pp. 117272-117272
Open Access | Times Cited: 19
Role of LipoprotEin(a) in CardiovascuLar Diseases and Premature Acute Coronary Syndromes (RELACS Study): impact of Lipoprotein(a) levels on the premature coronary event and the severity of coronary artery disease.
Arturo Cesaro, Vincenzo Acerbo, Francesco Scialla, et al.
Nutrition Metabolism and Cardiovascular Diseases (2024), pp. 103843-103843
Closed Access | Times Cited: 7
Association between Lipoprotein(a) and premature atherosclerotic cardiovascular disease: a systematic review and meta-analysis
Xu Tian, Nan Zhang, Gary Tse, et al.
European Heart Journal Open (2024) Vol. 4, Iss. 3
Open Access | Times Cited: 6
Daring to dream: Targeting lipoprotein(a) as a causal and risk-enhancing factor
Marlys L. Koschinsky, Erik S.G. Stroes, Florian Kronenberg
Pharmacological Research (2023) Vol. 194, pp. 106843-106843
Open Access | Times Cited: 14
Lipoprotein(a) distribution and its association with carotid arteriopathy in the Chinese population
Lijin Lin, Ke‐Qiong Deng, Ze Chen, et al.
Atherosclerosis (2023) Vol. 372, pp. 1-9
Open Access | Times Cited: 13
The nonlinear association between lipoprotein(a) and major adverse cardiovascular events in acute coronary syndrome patients with three-vessel disease
Qianhui Li, Shuailei Xu, Junxian Shen, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Rethinking Cardiovascular Risk: The Emerging Role of Lipoprotein(a) Screening
Victoria Clair, Francis Zirille, Edward A. Gill
American Journal of Preventive Cardiology (2025) Vol. 21, pp. 100945-100945
Open Access
Lipoprotein(a) as a Causal Risk Factor for Cardiovascular Disease
Sean Doherty, Sebastian Hernandez, Rishi Rikhi, et al.
Current Cardiovascular Risk Reports (2025) Vol. 19, Iss. 1
Open Access
Ischaemic stroke in young adults: an overview of the classification, risk factors, aetiologies and outcomes
Benjamin Yong‐Qiang Tan, Sarah Ming Li Tan, Michael Ng, et al.
Singapore Medical Journal (2025)
Open Access
Lipoprotein(a) in youth and childhood as a marker of cardiovascular risk stratification: a meta-analysis
Irene Borzillo, Fabrizio D ́ascenzo, Emanuele Ravetti, et al.
Journal of Cardiovascular Medicine (2025)
Closed Access
Lipoprotein(a) serum concentrations in children in relation to body mass index, age and sex
Paulina Stürzebecher, Konstantin L. Uttinger, Mandy Vogel, et al.
Pediatric Research (2024) Vol. 96, Iss. 1, pp. 177-183
Open Access | Times Cited: 4
The Link between Magnesium Supplements and Statin Medication in Dyslipidemic Patients
Roxana Nartea, Brînduşa Ilinca Mitoiu, Ioana Ghiorghiu
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 4, pp. 3146-3167
Open Access | Times Cited: 10
Evidence and Uncertainties on Lipoprotein(a) as a Marker of Cardiovascular Health Risk in Children and Adolescents
Simonetta Genovesi, Marco Giussani, Giulia Lieti, et al.
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1661-1661
Open Access | Times Cited: 9
Relationship Between Lipoprotein(a), Renal Function Indicators, and Chronic Kidney Disease: Evidence From a Large Prospective Cohort Study
Yingxin Liu, Ruoting Wang, Shuai Li, et al.
JMIR Public Health and Surveillance (2024) Vol. 10, pp. e50415-e50415
Open Access | Times Cited: 3
Acute coronary syndrome patterns in the Young: risk factor profile and in-hospital outcomes in a tertiary referral hospital in Kenya
Nadeem Kassam, Mzee Ngunga, Mohamed Hasham Varwani, et al.
BMC Cardiovascular Disorders (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Lipoprotein (a) and cerebrovascular disease
Constantine E. Kosmas, Maria D. Bousvarou, Evangelia Papakonstantinou, et al.
Journal of International Medical Research (2024) Vol. 52, Iss. 7
Open Access | Times Cited: 3
Genetically predicted lipoprotein(a) associates with coronary artery plaque severity independent of low-density lipoprotein cholesterol
Shoa L. Clarke, Rose D. L. Huang, Austin T. Hilliard, et al.
European Journal of Preventive Cardiology (2024)
Open Access | Times Cited: 3
Lipoprotein(a): a genetically determined risk factor for Cardiovascular disease
Santica M. Marcovina
Critical Reviews in Clinical Laboratory Sciences (2023) Vol. 60, Iss. 8, pp. 560-572
Closed Access | Times Cited: 7
Lipoprotein(a) throughout life in women
Pablo Corral, María G. Matta, Carlos A. Aguilar‐Salinas, et al.
American Journal of Preventive Cardiology (2024) Vol. 20, pp. 100885-100885
Open Access | Times Cited: 2
Role of Lipoprotein (A) in aortic valve stenosis: Novel disease mechanisms and emerging pharmacotherapeutic approaches
Mohammad Ishrak Khan, Raisa Subaita Zahir, Abel Casso Dominguez, et al.
IJC Heart & Vasculature (2024) Vol. 55, pp. 101543-101543
Open Access | Times Cited: 2
Coronary Artery Disease Risk Prediction in Young Adults: How Can We Overcome the Dominant Effect of Age?
Seyedmohammad Saadatagah, Mini G. Varughese, Vijay Nambi
Current Atherosclerosis Reports (2023) Vol. 25, Iss. 6, pp. 257-265
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top